Cargando…
A novel frameshift mutation of malonyl‐CoA decarboxylase deficiency: clinical signs and therapy response of a late‐diagnosed case
We evaluate the clinical findings and the treatment response of a late‐diagnosed case with a novel homozygous insertion c.13_14insG (p.P6Afs*202) result in a frameshift mutation in MLYCD gene. Both cardiac and neurologic involvements were mild when compared to previously reported cases, and see low‐...
Autores principales: | Ersoy, Melike, Akyol, Mehmet Bedir, Ceylaner, Serdar, Çakır Biçer, Nihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538191/ https://www.ncbi.nlm.nih.gov/pubmed/28781843 http://dx.doi.org/10.1002/ccr3.1013 |
Ejemplares similares
-
Chemical-genetic induction of Malonyl-CoA decarboxylase in skeletal muscle
por: Rodriguez, Susana, et al.
Publicado: (2014) -
Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction
por: Wang, Wei, et al.
Publicado: (2019) -
SIRT4 controls the balance between lipid synthesis and catabolism by repressing malonyl-CoA decarboxylase
por: Laurent, Gaëlle, et al.
Publicado: (2012) -
Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression
por: Zhou, Lijie, et al.
Publicado: (2023) -
Screening Phosphorylation Site Mutations in Yeast Acetyl-CoA Carboxylase Using Malonyl-CoA Sensor to Improve Malonyl-CoA-Derived Product
por: Chen, Xiaoxu, et al.
Publicado: (2018)